The DOI matches its Crossref record; 252 of the 252 references it cites were found in a registry or an index.
The evolution of SARS-CoV-2
Open accessAbstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused millions of deaths and substantial morbidity worldwide. Intense scientific effort to understand the biology of SARS-CoV-2 has resulted in daunting numbers of genomic sequences. We witnessed evolutionary events that could mostly be inferred indirectly before, such as the emergence of variants with distinct phenotypes, for example transmissibility, severity and immune evasion. This Review explores the mechanisms that generate genetic variation in SARS-CoV-2, underlying the within-host and population-level processes that underpin these events. We examine the selective forces that likely drove the evolution of higher transmissibility and, in some cases, higher severity during the first year of the pandemic and the role of antigenic evolution during the second and third years, together with the implications of immune escape and reinfections, and the increasing evidence for and potential relevance of recombination. In order to understand how major lineages, such as variants of concern (VOCs), are generated, we contrast the evidence for the chronic infection model underlying the emergence of VOCs with the possibility of an animal reservoir playing a role in SARS-CoV-2 evolution, and conclude that the former is more likely. We evaluate uncertainties and outline scenarios for the possible future evolutionary trajectories of SARS-CoV-2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The higher end of the ranges, with evolutionary rates up to 8 × 10 -3 substitutions per site per year, emphasises the potential for SARS-CoV-1 and similar coronaviruses to evolve rapidly, possibly even quicker than SARS-CoV-2.126”
From Severe acute respiratory syndrome (SARS) mathematical models and disease parameters: a systematic review (2025) · cites this paper as [126]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
EVOLUTION IN MENDELIAN POPULATIONS
Wright, S. (1931) · Genetics · doi:10.1093/genetics/16.2.97 · Cited by 9,237
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
Origin and evolution of pathogenic coronaviruses
Cui, J., Li, F., & Shi, Z. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0118-9 · Cited by 5,729
Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,910
Structural basis of receptor recognition by SARS-CoV-2
Shang, J., Ye, G., Shi, K., Wan, Y., Luo, C., Aihara, H., Geng, Q., Auerbach, A., & Li, F. (2020) · Nature · doi:10.1038/s41586-020-2179-y · Cited by 3,661
SARS-CoV-2 variants, spike mutations and immune escape
Harvey, W. T., Carabelli, A. M., Jackson, B., Gupta, R. K., Thomson, E. C., Harrison, E. M., Ludden, C., Reeve, R., Rambaut, A., COVID-19 Genomics UK (COG-UK) Consortium, et al. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00573-0 · Cited by 3,528
Nextstrain: real-time tracking of pathogen evolutionPreprint
Hadfield, J., Megill, C., Bell, S. M., et al. (2017) · bioRxiv · doi:10.1101/224048 · Cited by 3,172
Nextstrain: real-time tracking of pathogen evolution
Hadfield, J., Megill, C., Bell, S. M., Huddleston, J., Potter, B., Callender, C., Sagulenko, P., Bedford, T., & Neher, R. A. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty407 · Cited by 3,154
Cited by
Sorted by citations
Items 101–200 of 998
Virological characteristics correlating with SARS-CoV-2 spike protein fusogenicity
Begum, M. M., Ichihara, K., Takahashi, O., Nasser, H., Jonathan, M., Tokunaga, K., Yoshida, I., Nagashima, M., Sadamasu, K., Yoshimura, K., et al. (2024) · Frontiers in Virology · doi:10.3389/fviro.2024.1353661 · Cited by 14
Zhang, Y., Chamblee, M., Xu, J., Qu, P., Shamseldin, M. M., Yoo, S. J., Misny, J., Thongpan, I., Mahesh, K. C., Hall, J. M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49443-2 · Cited by 15
Liang, R., Liu, K., Li, Y., Zhang, X., Duan, L., Huang, M., Sun, L., Yuan, F., Zhao, J., Zhao, Y., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012415 · Cited by 15
Investigating the FLiRT variants of COVID-19: Is it an emerging concern?
Aden, D., & Zaheer, S. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155542 · Cited by 15
Beyond COVID-19: the promise of next-generation coronavirus vaccines
Mukesh, R. K., Yinda, C. K., Munster, V. J., & van Doremalen, N. (2024) · npj Viruses · doi:10.1038/s44298-024-00043-3 · Cited by 15
Cromer, D., Reynaldi, A., Mitchell, A., Schlub, T. E., Juno, J. A., Wheatley, A. K., Kent, S. J., Khoury, D. S., & Davenport, M. P. (2024) · Nature Communications · doi:10.1038/s41467-024-52194-9 · Cited by 15
Hong, H., Eom, E., Lee, H., Choi, S., Choi, B., & Kim, J. K. (2024) · Nature Communications · doi:10.1038/s41467-024-53095-7 · Cited by 15
Lee, J. S., Dittmar, M., Miller, J., Li, M., Ayyanathan, K., Ferretti, M., Hulahan, J., Whig, K., Etwebi, Z., Griesman, T., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115115 · Cited by 15
Chalkias, S., Pragalos, A., Akinsola, A., Berman, G., Ampajwala, M., Meyer, J. W., Schoch, L., Zhou, W., Paila, Y. D., Deng, W., et al. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf022 · Cited by 15
‘The end’ – Or is it? Emergence of SARS-CoV-2 EG.5 and BA.2.86 Subvariants
Rahimi, F., Darvishi, M., & Abadi, A. T. B. (2023) · Future Virology · doi:10.2217/fvl-2023-0150 · Cited by 15
Sherman, A. C., Gray, G., Cao, B., To, K. K., Rouphael, N., Restrepo, A. M. H., Gordon, A. C., & Baden, L. R. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00662-x · Cited by 19
SARS-CoV-2 Omicron: Viral Evolution, Immune Evasion, and Alternative Durable Therapeutic Strategies
Guo, H., Ha, S., Botten, J., Xu, K. Y., Zhang, N., An, Z., Strohl, W. R., Shiver, J. W., & Fu, T. (2024) · Viruses · doi:10.3390/v16050697 · Cited by 19
Herrmann, L., Breuer, J., Duc, T. N., Thomé, N., Ghazaani, F., Kamhieh‐Milz, S., Kamhieh‐Milz, J., & Pfützner, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-64406-9 · Cited by 14
A broad neutralizing nanobody against SARS-CoV-2 engineered from an approved drug
Liu, Q., Cai, C., 黄燕燕, Zhou, L., Guan, Y., Fu, S., Lin, Y., Yang, T., Yan, H., Zhang, Z., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06802-7 · Cited by 14
Subsequent Waves of Convergent Evolution in SARS-CoV-2 Genes and Proteins
Focosi, D., Spezia, P. G., & Maggi, F. (2024) · Vaccines · doi:10.3390/vaccines12080887 · Cited by 14
Yan, Q., Gao, X., Liu, B., Hou, R., He, P., Ma, Y., Zhang, Y., Zhang, Y., Li, Z., Chen, Q., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51770-3 · Cited by 15
Structure-guided mutations in CDRs for enhancing the affinity of neutralizing SARS-CoV-2 nanobody
Singh, V., Bhutkar, M., Choudhary, S., Nehul, S., Kumar, R., Singla, J., Kumar, P., & Tomar, S. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150746 · Cited by 14
Evolution takes multiple paths to evolvability when facing environmental change
Kumawat, B., Lalejini, A., Acosta, M. M., & Zaman, L. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2413930121 · Cited by 15
de Souza, U. J. B., Spilki, F. R., Tanuri, A., Roehe, P. M., & Campos, F. S. (2025) · Viruses · doi:10.3390/v17010064 · Cited by 14
Antiviral covalent ACE2 vesicle spray
Meng, Q., Han, Y., Liu, Y., Pan, P., Chen, R., Zhang, H., & Rao, L. (2025) · Cell Biomaterials · doi:10.1016/j.celbio.2025.100017 · Cited by 14
Ghafari, M., Kemp, S. A., Hall, M., Clarke, J., Luca Ferretti, A., Thomson, L., Studley, R., Rourke, E., COVID-19 Infection Survey Group, Walker, A. S., et al. (2025) · The Lancet Microbe · doi:10.1016/j.lanmic.2025.101154 · Cited by 14
Self-citationYang, J., Cui, Y., Yu, D., Zhang, G., Cao, R., Gu, Z., Dai, G., Wu, X., Ling, Y., Yi, C., et al. (2023) · Molecular Biology and Evolution · doi:10.1093/molbev/msad142 · Cited by 15
Structural basis for varying drug resistance of SARS-CoV-2 M pro E166 variants
Esler, M. A., Shi, K., Rollie, J. A., Delgado, R., Vishwakarma, J., Dąbrowska, A., Prahlad, J., Moghadasi, S. A., Harris, R. S., & Aihara, H. (2025) · mBio · doi:10.1128/mbio.02624-24 · Cited by 13
Lim, H. J., Lee, J. Y., Baek, Y.-H., Park, M., Youm, D.-J., Kim, I., Kim, M., Choi, J., Sohn, Y., Park, J.-E., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11123267 · Cited by 13
Chaki, S. P., Kahl-McDonagh, M. M., Neuman, B. W., & Zuelke, K. A. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1292467 · Cited by 13
Cagliani, R., Forni, D., Mozzi, A., Fuchs, R., Tussia-Cohen, D., Arrigoni, F., Pozzoli, U., GIOIA, L. D., Hagai, T., & Sironi, M. (2024) · Molecular Biology and Evolution · doi:10.1093/molbev/msae154 · Cited by 12
SARS-CoV-2 infection in microglia and its sequelae: What do we know so far?
Luo, E. Y., Chang, R. C., & Gilbert‐Jaramillo, J. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100888 · Cited by 14
Schöfbänker, M., Günther, T., Lorentzen, E. U., Romberg, M.-L., Hennies, M. T., Neddermeyer, R., Müller, M. M., Mellmann, A., Bojarzyn, C. R., Lenz, G., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012624 · Cited by 16
Barozi, V., Chakraborty, S., Govender, S., Morgan, E., Ramahala, R., Graham, S. C., Bishop, N. T., & Bishop, Ö. T. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.10.031 · Cited by 12
Adamescu, A.-I., Tilişcan, C., Stratan, L. M., Mihai, N., Ganea, O. A., Ciobanu, S., Marinescu, A. G., Aramă, V., & Aramă, Ș. S. (2025) · Medicina · doi:10.3390/medicina61040634 · Cited by 14
You, L., Zhang, L., Ouyang, S., Gao, B., Li, Y., Li, J., Wu, N., Wang, H., Sun, S., Li, J., et al. (2025) · Cell Discovery · doi:10.1038/s41421-025-00800-5 · Cited by 13
Carazo, S., Skowronski, D. M., Brousseau, N., Guay, C.-A., Sauvageau, C., Racine, É., Talbot, D. C., Ionescu, I. G., Fafard, J., Gilca, R., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0325269 · Cited by 14
Human cytokine and coronavirus nucleocapsid protein interactivity using large-scale virtual screens
Tomezsko, P. J., Ford, C. T., Meyer, A. E., Michaleas, A. M., & Jaimes, R. (2024) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2024.1397968 · Cited by 9
Generative prediction of real-world prevalent SARS-CoV-2 mutation with in silico virus evolution
Liu, X., Nie, Z., Si, H.-R., Shen, X., Liu, Y., Huang, X., Dong, T., Xu, F., Ren, Z., Zhou, P., et al. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf276 · Cited by 13
Chrysostomou, A. C., Vrancken, B., Haralambous, C., Alexandrou, M., Gregoriou, I., Ioannides, M., Iοannou, C., Kalakouta, O., Karagiannis, C., Marcou, M., et al. (2023) · Viruses · doi:10.3390/v15091933 · Cited by 13
Progress of SARS‐CoV‐2 Main protease peptide‐like inhibitors
Liu, X., Ren, X., Hua, M., Liu, F., Ren, X., Sui, C., Li, Q., Luo, F., Jiang, Z., Xia, Z., et al. (2023) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14425 · Cited by 12
Pontiroli, A. E., Scovenna, F., Carlini, V., Tagliabue, E., Martín-Delgado, J., Sala, L. L., Tanzi, E., & Zanoni, I. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29343 · Cited by 14
González‐Parra, G., Mahmud, M. S., & Kadelka, C. (2024) · Infectious Disease Modelling · doi:10.1016/j.idm.2024.05.005 · Cited by 15
Molecular determinants of cross-species transmission in emerging viral infections
Wickenhagen, A., van Tol, S., & Munster, V. J. (2024) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00001-23 · Cited by 12
Perevaryukha, A. Y. (2024) · Mathematical Models and Computer Simulations · doi:10.1134/s2070048224700078 · Cited by 12
Benlarbi, M., Ding, S., Bélanger, É., Tauzin, A., Poujol, R., Medjahed, H., Ferri, O. E., Bo, Y., Bourassa, C., Hussin, J., et al. (2024) · mBio · doi:10.1128/mbio.00907-24 · Cited by 12
Noviello, M., LORENZO, R. D., Chimienti, R., Maugeri, N., de Lalla, C., Siracusano, G., Lorè, N. I., Rancoita, P. M. V., Cugnata, F., Tassi, E., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1381091 · Cited by 13
Jorgensen, S. C. J., Hernandez, A., Buchan, S. A., Fitzpatrick, T., Guttmann, A., Morris, S. K., & Kwong, J. C. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae601 · Cited by 12
Evolution of SARS-CoV-2 in white-tailed deer in Pennsylvania 2021–2024
Marques, A. D., Hogenauer, M., Bauer, N., Gibison, M. L., DeMarco, B., Sherrill-Mix, S. A., Merenstein, C., Collman, R. G., Gagne, R. B., & Bushman, F. D. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1012883 · Cited by 12
Evolutionary Mechanisms of the Emergence of the Variants of Concern of SARS-CoV-2
Rouzine, I. M. (2025) · Viruses · doi:10.3390/v17020197 · Cited by 12
Itaconate and its derivatives as anti-pathogenic agents
Mazraani, R. A. A. D. A., Malys, N., & Malienė, V. (2025) · RSC Advances · doi:10.1039/d4ra08298b · Cited by 13
Immunological drivers of zoonotic virus emergence, evolution, and endemicity
Purushotham, J. N., Lutz, H. L., Parker, E., & Andersen, K. G. (2025) · Immunity · doi:10.1016/j.immuni.2025.03.014 · Cited by 15
The immunopathogenesis of SARS-CoV-2 infection: Overview of lessons learned in the first 5 years
Yang, O. O. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf033 · Cited by 14
The XEC Variant: Genomic Evolution, Immune Evasion, and Public Health Implications
Aljabali, A. A. A., Lundstrom, K. H., Hromić-Jahjefendić, A., El‐Baky, N. A., Nawn, D., Hassan, S. S., Rubio‐Casillas, A., Redwan, E. M. M. M., & Uversky, V. N. (2025) · Viruses · doi:10.3390/v17070985 · Cited by 12
SARS-CoV-2 Pneumonia: Advances in Diagnosis and Treatment
Căliman-Sturdza, O. A., Șoldănescu, I., & Gheorghita, R. E. (2025) · Microorganisms · doi:10.3390/microorganisms13081791 · Cited by 12
Csöbönyeiová, M., Smolinská, V., Harsányi, Š., Ivantysyn, M., & Klein, M. (2023) · Biomedicines · doi:10.3390/biomedicines11061736 · Cited by 11
Risk assessment of SARS-CoV-2 replicating and evolving in animals
Zhao, J., Kang, M., Wu, H., Sun, B., Baele, G., He, W., Lu, M., Suchard, M. A., Ji, X., He, N., et al. (2023) · Trends in Microbiology · doi:10.1016/j.tim.2023.07.002 · Cited by 12
Towards a Safer Future: Enhancing Vaccine Development to Combat Animal Coronaviruses
Si, F., Yu, R., Dong, S., Chen, B., Li, C., & Song, S. (2024) · Vaccines · doi:10.3390/vaccines12030330 · Cited by 11
Emergence of SARS and COVID-19 and preparedness for the next emerging disease X
Hu, B., Guo, H., Si, H.-R., & Shi, Z. (2024) · Frontiers of Medicine · doi:10.1007/s11684-024-1066-6 · Cited by 12
Characteristics and outcomes of cerebral venous thrombosis associated with COVID-19
Scutelnic, A., van de Munckhof, A. A. G. A., Angel Miraclin, T., Aaron, S., Hameed, S., Wasay, M., Grosu, O., Krzywicka, K., van Kammen, M. S., Lindgren, E., et al. (2024) · European Stroke Journal · doi:10.1177/23969873241241885 · Cited by 11
Protecting the vulnerable: addressing the COVID-19 care needs of people with compromised immunity
Razonable, R. R. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1397040 · Cited by 11
Will we ever know where covid-19 came from?
Looi, M.-K. (2024) · BMJ · doi:10.1136/bmj.q1578 · Cited by 11
Modified PEG-Lipids Enhance the Nasal Mucosal Immune Capacity of Lipid Nanoparticle mRNA Vaccines
Li, M., Yi, J., Lu, Y., Liu, T., Xing, H., Wang, X., Zhang, H., Liu, N., Wang, Z., & Zheng, A. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16111423 · Cited by 14
Townsend, J. P., Hassler, H. B., & Dornburg, A. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae559 · Cited by 13
Liao, Y., Ma, H., Wang, Z., Wang, S., He, Y., Chang, Y., Zong, H., Tang, H., Wang, L., Ke, Y., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2406659122 · Cited by 11
SARS-CoV-2 epidemiology, kinetics, and evolution: A narrative review
Alizon, S., & Sofonea, M. T. (2025) · Virulence · doi:10.1080/21505594.2025.2480633 · Cited by 14
Zhang, C., Min, Y.-Q., Xue, H., Zhang, H.-Y., Liu, K.-P., Tian, Y., Yang, Z., Zhao, Z., Yang, H., Chao, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61431-8 · Cited by 12
Traceability of SARS‐CoV‐2 transmission through quasispecies analysis
Messali, S., Rondina, A., Giovanetti, M., Bonfanti, C., Ciccozzi, M., Caruso, A., & Caccuri, F. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28848 · Cited by 11
Did covid-19 come from a lab leak in China?
Looi, M.-K. (2023) · BMJ · doi:10.1136/bmj.p1556 · Cited by 11
Neurological side effects and drug interactions of antiviral compounds against SARS‐CoV‐2
Akhvlediani, T., Bernard‐Valnet, R., Dias, S. P., Eikeland, R., Pfausler, B., & Sellner, J. (2023) · European Journal of Neurology · doi:10.1111/ene.16017 · Cited by 11
Jimenez, B. S., Sterling, T., Brown, A., Modica, B., Gibson, K., Collins, H., Koch, C., Schwarz, T., & Dye, K. N. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22356 · Cited by 11
IS IT TIME TO REFLECT, NOT ON THE “WHAT” BUT THE “WHY” IN EMERGING WILDLIFE DISEASE RESEARCH?
Kock, R. A. (2018) · Journal of Wildlife Diseases · doi:10.7589/2019-01-000 · Cited by 11
Recent advances in CRISPR-based diagnostics for single-nucleotide variant detection
Wang, M., Wang, Q., He, T., Liu, M., Zhang, Z., Zhao, L., Li, T., & Li, Y. (2025) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2025.118505 · Cited by 11
Infection, Dysbiosis and Inflammation Interplay in the COVID Era in Children
Ailioaie, L. M., Ailioaie, C., & Litscher, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310874 · Cited by 10
Spike2CGR: an efficient method for spike sequence classification using chaos game representation
Murad, T., Ali, S., Khan, I., & Patterson, M. (2023) · Machine Learning · doi:10.1007/s10994-023-06371-4 · Cited by 10
Popovic, M. E., Pavlović, M. R. P., & Popović, M. (2023) · Microbial Risk Analysis · doi:10.1016/j.mran.2023.100280 · Cited by 10
Rus, K. R., Zakotnik, S., Sagadin, M., Kolenc, M., Skubic, L., Knap, N., Korva, M., Poljak, M., & Avšič‐Županc, T. (2024) · Acta Dermatovenerologica Alpina Pannonica et Adriatica · doi:10.15570/actaapa.2024.1 · Cited by 10
Durability of humoral and cellular immunity six months after the BNT162b2 bivalent booster
Favresse, J., Gillot, C., Closset, M., Cabo, J., Wauthier, L., David, C., Elsen, M., Dogné, J., & Douxfils, J. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29365 · Cited by 10
Kibria, M. K., Ali, M. A., Yaseen, M., Khan, I. A., Bhat, M. A., Islam, M. A., Mahumud, R. A., & Mollah, M. N. H. (2024) · Pharmaceuticals · doi:10.3390/ph17040432 · Cited by 10
Assessing the emergence time of SARS-CoV-2 zoonotic spillover
Samson, S., Lord, É., & Makarenkov, V. (2024) · PLoS ONE · doi:10.1371/journal.pone.0301195 · Cited by 10
SARS-CoV-2 Omicron subvariants progressively adapt to human cells with altered host cell entry
Sakurai, Y., Okada, S., Ozeki, T., Yoshikawa, R., Kinoshita, T., & Yasuda, J. (2024) · mSphere · doi:10.1128/msphere.00338-24 · Cited by 12
Bezerra, P. R., & Almeida, F. C. L. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107834 · Cited by 10
Cao, Y., Lai, K. M., Fu, K.-C., Kuo, C.-L., Tan, Y., Yu, L. L., & Huang, D. (2024) · Foods · doi:10.3390/foods13203274 · Cited by 10
Antiviral combination treatment strategies for SARS-CoV-2 infection in immunocompromised patients
Sepulcri, C., Bartalucci, C., & Mikulska, M. (2024) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000001070 · Cited by 10
Chen, J., Li, Y., Liu, X., Li, H., Zhu, J., Ma, R., Tian, L., Yu, L., Li, J., Liu, Z., et al. (2024) · Chem · doi:10.1016/j.chempr.2024.10.021 · Cited by 10
Huang, Z., Wang, Z., Liu, Y., Ke, C., Feng, J., He, B., & Jiang, T. (2024) · Microbiome · doi:10.1186/s40168-024-01950-6 · Cited by 11
Outcome of SARS-CoV-2 reinfection depends on genetic background in female mice
Singh, G., Diego, J. G.-B., Warang, P., Park, S., Chang, L. A., Noureddine, M., Laghlali, G., Bykov, Y., Prellberg, M., Yan, V., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54334-7 · Cited by 9
Naiditch, H., Betts, M. R., Larman, H. B., Levi, M., & Rosenberg, A. Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1376654 · Cited by 10
Chakraborty, C., Bhattacharya, M., & Abdelhameed, A. S. (2025) · Virology · doi:10.1016/j.virol.2025.110508 · Cited by 11
Berlanga, J. J., Matamoros, T., Rodríguez‐Pulido, M., Sáiz, M., Bayón, M. N., Toribio, R., & Ventoso, I. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf261 · Cited by 11
Lear, T., Larsen, M. B., Lin, B., Treat, B. R., Cao, Q. N., Boudreau, Á. N., Lockwood, K. C., Alfaras, I., Kennerdell, J. R., Salminen, L., et al. (2025) · Science Advances · doi:10.1126/sciadv.adv4033 · Cited by 11
Sustained excess all-cause mortality post COVID-19 in 21 countries: an ecological investigation
Pallari, C. T., Achilleos, S., Quattrocchi, A., Haghighi, M. R. R., Phan, M. T., Artemiou, A., Bennett, C. M., Cuthbertson, J. L., Zimmermann, C. S., Schernhammer, E. S., et al. (2025) · International Journal of Epidemiology · doi:10.1093/ije/dyaf075 · Cited by 10
Codon Usage Bias in Human RNA Viruses and Its Impact on Viral Translation, Fitness, and Evolution
Ventoso, I. (2025) · Viruses · doi:10.3390/v17091218 · Cited by 11
Marín-Machuca, O., Chacón, R. D., Alvarez-Lovera, N., Pesantes-Grados, P., Pérez-Timaná, L., & Marín-Sánchez, O. (2023) · Vaccines · doi:10.3390/vaccines11111648 · Cited by 10
Predicting the spread of SARS-CoV-2 variants: An artificial intelligence enabled early detection
Levi, R., Zerhouni, E. G., & Altuvia, S. (2023) · PNAS Nexus · doi:10.1093/pnasnexus/pgad424 · Cited by 11
Leveraging SARS-CoV-2 Main Protease (Mpro) for COVID-19 Mitigation with Selenium-Based Inhibitors
Luca, V. D., Angeli, A., Nocentini, A., Gratteri, P., Pratesi, S., Tanini, D., Carginale, V., Capperucci, A., Supuran, C. T., & Capasso, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020971 · Cited by 10
Giovanetti, M., Cella, E., Ivanov, I. N., Grigorova, L., Stoikov, I., Donchev, D., Dimitrova, R., Slavov, S. N., Mavian, C. N., Fonseca, V., et al. (2023) · Viruses · doi:10.3390/v15091924 · Cited by 9
Zhang, X., Lam, S. J.-A., Ip, J. D., Fong, C. H.-Y., Chu, A. W., Chan, W.-M., Lai, Y. S.-Y., Tsoi, H., Chan, B. P.-C., Chen, L., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109706 · Cited by 10
Tachibana, K., Nakamura, Y., Ly, T. K., Kihara, T., Kawada, H., Yamamoto, N., & Ando, K. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150120 · Cited by 9
Olgotrelvir as a Single-Agent Treatment of Nonhospitalized Patients with Covid-19
Jiang, R., Han, B., Xu, W., Zhang, X., Peng, C., Dang, Q., Sun, W., Lin, L., Lin, Y., Fan, L., et al. (2024) · NEJM Evidence · doi:10.1056/evidoa2400026 · Cited by 9
Iftimie, S. M., Gabaldó-Barrios, X., Nadal, J. P., Canela-Capdevila, M., Piñana, R., Jiménez-Franco, A., López-Azcona, A. F., Castañé, H., Cárcel, M., Camps, J., et al. (2024) · Viruses · doi:10.3390/v16071065 · Cited by 10
Choi, A. N. X., Siriphanitchakorn, T., Choy, M. M. J., Ooi, J. S. G., Manuel, M., Tan, H. C., Lin, L. Z., Yap, X., Gubler, D. J., & Ooi, E. E. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adk4769 · Cited by 9
Quek, A. M. L., Wang, S., Teng, O., Shunmuganathan, B. D. O., Er, B. G. C., Mahmud, N. F. B., Ng, I. X. Q., Gupta, R., Tan, I. S. L., Tan, N. Y. J., et al. (2024) · Journal of Infection · doi:10.1016/j.jinf.2024.106238 · Cited by 9
High-resolution epidemiological landscape from ~290,000 SARS-CoV-2 genomes from Denmark
Khurana, M. P., Curran-Sebastian, J. L., Scheidwasser, N., Morgenstern, C., Rasmussen, M., Fonager, J., Stegger, M., Tang, M. E., Juul, J. L., Escobar-Herrera, L. A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51371-0 · Cited by 9
Human behavior-based COVID-19 transmission in two dining spaces
Xu, Z., Zhang, H., Zhu, M. S., Ji, Y., Xue, P., Xie, J., Li, Y., & Zhang, N. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.135820 · Cited by 9
Metadata
- Authors
- Markov, P. V., Ghafari, M., Beer, M., Lythgoe, K., Simmonds, P., Stilianakis, N. I., & Katzourakis, A.
- Affiliations
- University of London (GB)
- University of Oxford (GB)
- Friedrich-Loeffler-Institut (DE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Corresponding author
- Markov, Peter V.
- Katzourakis, Aris
- ORCID
- Venue
- Nature Reviews Microbiology
- Published
- 2023-04-05
- Volume
- 21
- Issue
- 6
- Pages
- 361-379
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W4362609000
- Semantic Scholar
- b6c3324e790174aac7a7b28fcfe0bc22f5461418
- Cited by
- 1,179
- References
- 225
- Citations by year
- 2026: 204 · 2025: 390 · 2024: 441 · 2023: 130
- FWCI
- 55.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- OpenAgrar (submittedVersion)
- Funders
- Wellcome Trust (107652/Z/15/Z)
- H2020 European Research Council (101001623)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Keywords
- SARS-CoV-2, viral evolution, genetic variation, variants of concern, antigenic evolution, immune evasion, reinfection, recombination, chronic infection, reservoir hosts, transmissibility, disease severity, COVID-19 pandemic, evolutionary trajectories
- MeSH terms
- COVID-19, SARS-CoV-2, Animals, Genomics, Immune Evasion, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
